Baijiayun Group Ltd ("Baijiayun" or the "Company") , a one-stop AI video solution provider, announced that Duanxunbao, its flagship product, has received a major upgrade this winter. After the upgrade ...

The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft-versus-host disease (SR-aGVHD) in children two ...

1月2日，我国首款干细胞药物艾米迈托赛注射液（商品名：睿铂生®）通过国家药品监督管理局（NMPA）优先审评审批程序附条件批准上市，用于治疗14岁以上消化道受累为主的激素治疗失败的急性移植物抗宿主病（aGVHD）。